trial

Cognitive Remediation in Schizophrenia: Efficacy and Role of Neuroplasticity in "Top-down" and "Bottom-up" Mechanisms

NCTId NCT06482918
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 160 (estimated)
Sponsored by University of Chile
Primary completion 2026-03-15
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
160 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2024-06
Primary completion
2026-03-15
Eligibility
ALL · 18 Years · 59 Years

Interventions & indications

Drugs
Cognitive Remediation

Sponsors

University of ChileLead Sponsor

Investigators

1
Rodrigo R. Nieto, MD PhDPrincipal Investigator

Sites

1 total
Santiago, Chile

Facts & assertions

4 sourced
Enrollment
160
Phase
NA
Primary Completion Date
2026-03-15
Status
UNKNOWN
relationships
The graph out of here
drug
Cognitive Remediation
drug
lead_sponsor
University of Chile
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Rodrigo R. Nieto, MD PhD
person